Validity and Reliability of VO2-max Measurements in Persons With Parkinson's Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

20 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-01

Study Completion Date

2022-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Each participant would complete four test days and each test day is separated by 7-10 days. At each test day the participants would complete a graded maximal exercise test (VO2max-test), a chair rise (Linear encoder) as well as measuring of basic demographic outcomes (weight, fat%,blood pressure etc.). The first test day would further include a motor (MDS-UPDRS III) and cognitive examination (MoCA), a questionnaire about quality of life (PDQ-39) and one about depression (BDI-II). Furthermore, the first test day would include two test of walking performance (6 minutes walk test and Time Up and Go). Two of the test days would be completed while the participants are off their Parkinson disease medication for at least 12 hours, while the other two test days would be completed while on their Parkinson medication. The order of the tests would be randomized. It is hypothesized that the VO2max test would be reliable and valid when participants are on medication, while off-medication would affect the reliability and validity.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Effects of 24-Weeks Community-based Brisk Walking in People With Parkinson's Disease

NCT06707402

Parkinson Disease

RECRUITING NA

The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD)

NCT01391741

Parkinson´s Disease

COMPLETED PHASE3

Aerobic Exercise and Brain Health in Parkinson's

NCT04379778

Parkinson Disease

COMPLETED NA

Effects of Nordic Walking in Parkinson Disease Patients

NCT03355521

Parkinson Disease Parkinson Disease 10

COMPLETED NA

Measures of Motor Impairment in Early Parkinson's Disease

NCT00291265

Parkinson's Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Parkinson Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 40 year
* Written informed consent
* Diagnosed with idiopathic Parkinson's disease
* Hoehn \& Yahr ≤ 3
* Taking dopaminergic medication
* Able to complete a maximal aerobic test on a bicycle

Exclusion Criteria

* Dementia
* Alcohol abuse
* Pacemaker
* Serious cardiovascular, respiratory, orthopedic or other comorbidities excluding maximal exercise participation.
* Pregnancy

Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No